What's in Nutricion Medica S.L.'s pipeline?

Nutricion Medica S.L. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Nutricion Medica S.L.'s portfolio?

Top competitors by shared drug class: National Center for Complementary and Integrative Health (NCCIH).

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nutricion-medica-s-l.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Nutricion Medica S.L. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nutricion Medica S.L. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Passiflora incarnata	Passiflora incarnata	marketed	Herbal anxiolytic/sedative	GABA receptors, serotonin receptors (non-selective)	Psychiatry/Neurology

Therapeutic area mix

Psychiatry/Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

National Center for Complementary and Integrative Health (NCCIH) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nutricion Medica S.L.:

Cite this brief

Drug Landscape (2026). Nutricion Medica S.L. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nutricion-medica-s-l. Accessed 2026-05-17.